×îÐÂÐÓ°ÉÔ­´´

The Rare Disease Foundation (RDF) is pleased to announce the new Innovative Therapies Program. This is a program of up to $25,000 grants available to conduct pilot or early stage human clinical trials for any kind of therapy to improve the lives of those with rare conditions. 

As with RDF's micro-grants, applications are short, de-identified, and reviewed by multiple scientific, medical, and lay reviewers. Up to four grants are available. 

Proposals are due Jan. 31, 2019Ìý²¹²Ô»å are available.

If you are interested in purusing this opportunity, please contact david.spurrell@dal.ca